OCS
NASDAQ · Pharmaceuticals
Oculis Holding Ag
$31.35
+0.26 (+0.84%)
Open$31.02
Previous Close$31.09
Day High$31.74
Day Low$30.90
52W High$31.33
52W Low$16.00
Volume—
Avg Volume433.6K
Market Cap1.78B
P/E Ratio—
EPS$-1.92
SectorPharmaceuticals
Analyst Ratings
Strong Buy
15 analysts
Price Target
-12.9% upside
Current
$31.35
$31.35
Target
$27.31
$27.31
$14.95
$27.31 avg
$37.18
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 335.81M | 321.14M | 281.93M |
| Net Income | 75.81M | 72.36M | 63.56M |
| Profit Margin | 22.6% | 22.5% | 22.5% |
| EBITDA | 137.16M | 117.64M | 104.92M |
| Free Cash Flow | 80.35M | 48.21M | 59.98M |
| Rev Growth | +1.2% | -6.4% | +18.4% |
| Debt/Equity | 0.56 | 0.65 | 0.60 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |